Eiji Nanba
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eiji Nanba has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Toshiyuki Yamamoto
Institute of Medical Genetics, Tokyo Women's Medical University, Tokyo, Japan, Japan
3 shared publications Katsumi Higaki
2 shared publicationsShinji Maegawa
Division of Functional Genomics, Research Center for Bioscience and Technology, Tottori University, 86 Nishicho, Yonago, Tottori 683-8503, Japan
2 shared publicationsAtsushi Takahashi
Central Research Laboratories
1 shared publicationChieko Kato
Department of Psychiatry, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
1 shared publicationEtsuko Ueta
1 shared publication
Latest Publications
- 4 November 2014
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 6 (2) , 306-310
Potent chemical chaperone compounds for GM1-gangliosidosis: N-substituted (+)-conduramine F-4 derivatives
The development of second-generation valienamine-type chemical chaperones for GM1-gangliosidosis is described. Several N-substituted (+)-conduramine F-4 derivatives were designed as novel chemical chaperones based on a lead chaperone compound, N-octyl-4-epi-β-valienamine, to decrease the inhibitory activity while increasing the enzyme enhancement activity. Among the derivatives synthesized during this study, a conduramine derivative with an N-cyclohexylmethyl group has demonstrated significant enhancement of R201C mutated β-galactosidase activity.
- 4 November 2014
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 6 (2) , 306-310
Potent chemical chaperone compounds for GM1-gangliosidosis: N-substituted (+)-conduramine F-4 derivatives
The development of second-generation valienamine-type chemical chaperones for GM1-gangliosidosis is described. Several N-substituted (+)-conduramine F-4 derivatives were designed as novel chemical chaperones based on a lead chaperone compound, N-octyl-4-epi-β-valienamine, to decrease the inhibitory activity while increasing the enzyme enhancement activity. Among the derivatives synthesized during this study, a conduramine derivative with an N-cyclohexylmethyl group has demonstrated significant enhancement of R201C mutated β-galactosidase activity.
- Open Access
- 1 September 2007
- Published by Elsevier in Brain and Development
- Vol. 29 (8) , 491-495
Imprinting status of paternally imprinted DLX5 gene in Japanese patients with Rett syndrome
- 1 September 2007
- Published by Elsevier in Brain and Development
- Vol. 29 (8) , 491-495
Open AccessImprinting status of paternally imprinted DLX5 gene in Japanese patients with Rett syndrome
- 28 June 2004
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 131B (1) , 43-47
Association between the neurofibromatosis‐1 (NF1) locus and autism in the Japanese population
Autistic patients have a 100 to 190-fold increased risk of neurofibromatosis compared to the general population. This suggests that the two diseases may share a common etiological background. Recently, a new allele (or the six-repeat allele) of the (AAAT)n repeat polymorphism in an Alu sequence in the neurofibromatosis-1 (NF1) gene was observed exclusively in severe autistic patients, not in controls, in Caucasians of French ancestry. This suggests a role of the NF1 gene in the development of autism. We investigated three microsatellite polymorphisms within the intron-27b and intron-38 of the NF1 region, including the (AAAT)n and two (CA)n repeat polymorphisms, in Japanese subjects with autism (n = 74) and controls (n = 122). The six-repeat allele of the (AAAT)n polymorphism was not found either in patients or controls, possibly indicating an ethnic difference in the polymorphism. However, significant differences were observed in the allele distributions of the (AAAT)n and a (CA)n, which were located at intron-27b, between patients and controls, although an association was not significant between autism and another polymorphism at intron-38. This may suggest an involvement of the NF1 locus in susceptibility to autism, although further investigations are recommended.
- 28 June 2004
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 131B (1) , 43-47
Association between the neurofibromatosis‐1 (NF1) locus and autism in the Japanese population
Autistic patients have a 100 to 190-fold increased risk of neurofibromatosis compared to the general population. This suggests that the two diseases may share a common etiological background. Recently, a new allele (or the six-repeat allele) of the (AAAT)n repeat polymorphism in an Alu sequence in the neurofibromatosis-1 (NF1) gene was observed exclusively in severe autistic patients, not in controls, in Caucasians of French ancestry. This suggests a role of the NF1 gene in the development of autism. We investigated three microsatellite polymorphisms within the intron-27b and intron-38 of the NF1 region, including the (AAAT)n and two (CA)n repeat polymorphisms, in Japanese subjects with autism (n = 74) and controls (n = 122). The six-repeat allele of the (AAAT)n polymorphism was not found either in patients or controls, possibly indicating an ethnic difference in the polymorphism. However, significant differences were observed in the allele distributions of the (AAAT)n and a (CA)n, which were located at intron-27b, between patients and controls, although an association was not significant between autism and another polymorphism at intron-38. This may suggest an involvement of the NF1 locus in susceptibility to autism, although further investigations are recommended.
- 1 May 2003
- Published by Georg Thieme Verlag KG in International Journal of Angiology
- Vol. 12 (02) , 103-110
Relationship of matrix metalloproteinases 2 and 9 in the wall of abdominal aortic aneurysms
This study examines the pathogenesis of abdominal aortic aneurysms (AAAs) with respect to pathological characteristics and expressions of matrix metalloproteinases (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinases (TIMP)-1, in Tottori University Hospital, Japan. Thirty-four consecutive patients were operated on for (AAAs). During surgery, the anterior wall of the aneurysmal aorta was resected from the site of maximal diameter throughout the wall. AAA specimens consisted of the aneurysmal aortas, while control specimens consisted of the undulated aortas of autopsy cases. The expression of MMP-2, MMP-9 and TIMP-1 was evaluated by immunohistochemistry, Western blotting and competitive polymerase chain reaction (C-PCR). Immunohistochemistry showed MMP-2-positive cells and TIMP-1 positive cells mainly in the intima, and MMP-9-positive cells in the intima and adventitia. Western blotting revealed the expression of MMPs and TIMP-l variably in all the cases examined. C-PCR showed significantly higher elevation of MMP-2 mRNA in the small-diameter AAAs (30–45 mm), plus higher MMP-9 mRNA expression in both the small-diameter and the medium-large-diameter AAAs (45 < mm), than in controls. The ratio of MMP-2 to TIMP-1 mRNA levels in the small-diameter AAAs, and the ratio of MMP-9 to TIMP-1 mRNA levels in both the small-diameter and medium-large-diameter AAAs were significantly higher than in controls. The mRNA levels were significantly correlated between MMP-2 and MMP-9, between MMP-2 and TIMP-1, and between MMP-9 and TIMP-1 in the AAAs. This study demonstrates that increases in mRNA imbalanced expression of MMPs/TIMP, as well as increases of MMP-2 and MMP-9 expression, may play crucial roles in the development and growth of AAAs, and TIMP-1 may play an important rule of preventing the aortic expansion.
- 1 May 2003
- Published by Georg Thieme Verlag KG in International Journal of Angiology
- Vol. 12 (02) , 103-110
Relationship of matrix metalloproteinases 2 and 9 in the wall of abdominal aortic aneurysms
This study examines the pathogenesis of abdominal aortic aneurysms (AAAs) with respect to pathological characteristics and expressions of matrix metalloproteinases (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinases (TIMP)-1, in Tottori University Hospital, Japan. Thirty-four consecutive patients were operated on for (AAAs). During surgery, the anterior wall of the aneurysmal aorta was resected from the site of maximal diameter throughout the wall. AAA specimens consisted of the aneurysmal aortas, while control specimens consisted of the undulated aortas of autopsy cases. The expression of MMP-2, MMP-9 and TIMP-1 was evaluated by immunohistochemistry, Western blotting and competitive polymerase chain reaction (C-PCR). Immunohistochemistry showed MMP-2-positive cells and TIMP-1 positive cells mainly in the intima, and MMP-9-positive cells in the intima and adventitia. Western blotting revealed the expression of MMPs and TIMP-l variably in all the cases examined. C-PCR showed significantly higher elevation of MMP-2 mRNA in the small-diameter AAAs (30–45 mm), plus higher MMP-9 mRNA expression in both the small-diameter and the medium-large-diameter AAAs (45 < mm), than in controls. The ratio of MMP-2 to TIMP-1 mRNA levels in the small-diameter AAAs, and the ratio of MMP-9 to TIMP-1 mRNA levels in both the small-diameter and medium-large-diameter AAAs were significantly higher than in controls. The mRNA levels were significantly correlated between MMP-2 and MMP-9, between MMP-2 and TIMP-1, and between MMP-9 and TIMP-1 in the AAAs. This study demonstrates that increases in mRNA imbalanced expression of MMPs/TIMP, as well as increases of MMP-2 and MMP-9 expression, may play crucial roles in the development and growth of AAAs, and TIMP-1 may play an important rule of preventing the aortic expansion.
- 17 July 2002
- Published by Wiley in Annals of Neurology
- Vol. 52 (3) , 351-355
Niemann–Pick type C disease: Accelerated neurofibrillary tangle formation and amyloid β deposition associated with apolipoprotein E ε4 homozygosity
Niemann–Pick type C disease is a neurovisceral storage disorder. Neurofibrillary tangles similar to those in Alzheimer's disease have been reported in most juvenile/adult patients without amyloid β protein (Aβ) deposits. Recently, we found deposits of Aβ in the form of diffuse plaques in three (31‐ and 32‐year‐old sisters and a 37‐year‐old man) of nine Niemann–Pick type C disease patients, who presented with most severe tauopathy and with numerous neurofibrillary tangles. Aβ deposits were not detected in any of the control brains of patients younger than age 42 years. These three patients with Aβ deposit all were homozygotes of apolipoprotein E ε4. Our study suggested that NPC1 gene mutations combined with homozygosity of apolipoprotein E ε4 alleles could manifest neuropathology similar to that of Alzheimer's disease. Investigation of these patients may provide an important clue for understanding the pathogenesis of Alzheimer's disease.
- 17 July 2002
- Published by Wiley in Annals of Neurology
- Vol. 52 (3) , 351-355
Niemann–Pick type C disease: Accelerated neurofibrillary tangle formation and amyloid β deposition associated with apolipoprotein E ε4 homozygosity
Niemann–Pick type C disease is a neurovisceral storage disorder. Neurofibrillary tangles similar to those in Alzheimer's disease have been reported in most juvenile/adult patients without amyloid β protein (Aβ) deposits. Recently, we found deposits of Aβ in the form of diffuse plaques in three (31‐ and 32‐year‐old sisters and a 37‐year‐old man) of nine Niemann–Pick type C disease patients, who presented with most severe tauopathy and with numerous neurofibrillary tangles. Aβ deposits were not detected in any of the control brains of patients younger than age 42 years. These three patients with Aβ deposit all were homozygotes of apolipoprotein E ε4. Our study suggested that NPC1 gene mutations combined with homozygosity of apolipoprotein E ε4 alleles could manifest neuropathology similar to that of Alzheimer's disease. Investigation of these patients may provide an important clue for understanding the pathogenesis of Alzheimer's disease.
- 26 September 2000
- Published by Hindawi Limited in Human Mutation
- Vol. 16 (4) , 375
Two novel serine repeat length polymorphisms (1043insS and 1043inssS) at exon 23 of theTSC1 gene
- 26 September 2000
- Published by Hindawi Limited in Human Mutation
- Vol. 16 (4) , 375
Two novel serine repeat length polymorphisms (1043insS and 1043inssS) at exon 23 of theTSC1 gene